Exercise vs. extended-release niacin in patients with coronary heart disease and low HDL [high density lipoprotein] cholesterol: effect on lipid profile and endothelial function.
Phase of Trial: Phase IV
Latest Information Update: 17 Aug 2018
At a glance
- Drugs Niacin (Primary)
- Indications Heart disorders; Low HDL cholesterol
- Focus Biomarker; Pharmacodynamics
- 30 Jul 2012 Actual end date (Jun 2009) added as reported by ClinicalTrials.gov record.
- 11 Apr 2009 Status changed from recruiting to active, no longer recruiting.
- 08 Oct 2006 New trial record.